These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4020151)

  • 1. Neutrophil leucocyte chemotaxis: a simplified assay for measuring polarizing responses to chemotactic factors.
    Haston WS; Shields JM
    J Immunol Methods; 1985 Aug; 81(2):229-37. PubMed ID: 4020151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotactic and enzyme-releasing activity of amphipathic proteins for neutrophils. A possible role for protease in chemotaxis on substratum-bound protein gradients.
    Wilkinson PC; Bradley GR
    Immunology; 1981 Apr; 42(4):637-48. PubMed ID: 7016748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation to chemotactic factor gradients to neutrophil migration and orientation under agarose.
    Udén AM; Hafström I; Palmblad J
    J Leukoc Biol; 1986 Jan; 39(1):27-35. PubMed ID: 3001211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of equine neutrophil chemotaxis and chemokinesis by a Taenia taeniaeformis proteinase inhibitor, taeniaestatin.
    Leid RW; Grant RF; Suquet CM
    Parasite Immunol; 1987 Mar; 9(2):195-204. PubMed ID: 3574975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do leucocytes perceive chemical gradients?
    Wilkinson PC
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):303-11. PubMed ID: 2073411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device.
    Li Jeon N; Baskaran H; Dertinger SK; Whitesides GM; Van de Water L; Toner M
    Nat Biotechnol; 2002 Aug; 20(8):826-30. PubMed ID: 12091913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of synthetic chemotactic peptides on neutrophil function.
    Patrone F; Dallegri F; Bonvini E; Sacchetti C
    Int Arch Allergy Appl Immunol; 1980; 62(3):316-23. PubMed ID: 7390636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behaviour of neutrophil leucocytes in uniform concentrations of chemotactic factors: contraction waves, cell polarity and persistence.
    Shields JM; Haston WS
    J Cell Sci; 1985 Mar; 74():75-93. PubMed ID: 3161901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil chemotaxis in patients with Staphylococcus aureus furunculosis.
    Cates KL; Quie PG
    Infect Immun; 1979 Dec; 26(3):1004-8. PubMed ID: 393626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of chemotaxis of polymorphonuclear leukocytes in vitro. The problems of the control of gradients of chemotactic factors, of the control of the cells and of the separation of chemotaxis from chemokinesis.
    Bignold LP
    J Immunol Methods; 1988 Apr; 108(1-2):1-18. PubMed ID: 3280683
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell polarity: an examination of its behavioral expression and its consequences for polymorphonuclear leukocyte chemotaxis.
    Zigmond SH; Levitsky HI; Kreel BJ
    J Cell Biol; 1981 Jun; 89(3):585-92. PubMed ID: 7251666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of neutrophil shape change by an inhibitor of chemotaxis.
    Donabedian H; Sawyer T; Senitzer D
    J Leukoc Biol; 1987 Nov; 42(5):510-8. PubMed ID: 3479513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multifunctional receptor on the neutrophil for synthetic chemotactic oligopeptides.
    Becker EL
    J Reticuloendothel Soc; 1979 Dec; 26(Suppl):701-9. PubMed ID: 392088
    [No Abstract]   [Full Text] [Related]  

  • 14. Antirheumatic drug effects on neutrophil response to chemotactic factors: a comparison of analytical techniques.
    Turner RA; Johnson JA; Semble EL
    Proc Soc Exp Biol Med; 1983 Jun; 173(2):200-4. PubMed ID: 6408645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotactic peptide from ropalidian wasp as well as the authentic chemotactic tripeptide stimulates two distinct pathways in neutrophils, but the [LYS7] analog does only one of them.
    Koike M; Nagashima K; Saito K; Nakanishi M; Fujino M; Nakajima T
    Biochem Biophys Res Commun; 1991 Feb; 175(1):165-72. PubMed ID: 1847803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ascorbic acid on neutrophil locomotion.
    Dallegri F; Lanzi G; Patrone F
    Int Arch Allergy Appl Immunol; 1980; 61(1):40-5. PubMed ID: 7350124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung.
    Robbins RA; Gossman GL; Nelson KJ; Koyama S; Thompson AB; Rennard SI
    Am Rev Respir Dis; 1990 Oct; 142(4):763-8. PubMed ID: 2221580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils.
    Laskin DL; Kimura T; Sakakibara S; Riley DJ; Berg RA
    J Leukoc Biol; 1986 Mar; 39(3):255-66. PubMed ID: 3456007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chapter 15. A microfluidics-based method for chemoattractant gradients.
    Lin F
    Methods Enzymol; 2009; 461():333-47. PubMed ID: 19480926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.